Loading organizations...
Loading organizations...
Clinical-stage biotech developing innovative combination medicines.
InxMed has raised $84.0M across 3 funding rounds.
InxMed has raised $84.0M in total across 3 funding rounds.
InxMed has raised $84.0M in total across 3 funding rounds.
InxMed's investors include Dr. Sylvia Xin He, Hua Yi, AIHC Capital, Growth Fund, Hosencare Fund, China Growth Capital, Grand Yangtze Capital.
InxMed has raised $84.0M across 3 funding rounds. Most recently, it raised $15.0M Series B in May 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 9, 2022 | $15.0M Series B | Dr. Sylvia Xin He | |
| Mar 4, 2022 | $50.0M Series B | Hua Yi | AIHC Capital, Growth Fund, Hosencare Fund |
| Sep 4, 2020 | $19.0M Series A | China Growth Capital | Grand Yangtze Capital |